Lunesta

Lunesta is the Z-drug that gets reached for when Ambien isn’t holding the night together. Same family, different shape, slightly longer half-life. It binds the same GABA-A receptor real benzodiazepines do, just at a narrower subunit, which is the trick the whole Z-drug class is built around. Less anxiolytic effect, less muscle relaxation, mostly just sleep. That’s the pitch.

Generic name eszopiclone. Schedule IV. Doses come in 1mg, 2mg, and 3mg, and most adults end up at 2mg. Older adults and anyone with liver issues start at 1mg and stay there. The 3mg dose exists but it’s where the side effect profile starts to bite, and I rarely write for it unless we’ve already tried everything else.

The thing Lunesta is genuinely good for is sleep maintenance. If you’re the person who falls asleep fine but wakes at 3 AM and can’t get back down, this is the Z-drug that actually has the half-life to hold you through. Ambien clears too fast for that pattern. Lunesta has roughly a six-hour half-life, which is the entire reason it exists as a separate molecule. The flip side of that longer half-life is the part patients aren’t warned about often enough.

The morning hangover and the metallic taste

Two things you should know before the first dose. First, you can wake up groggy. Ambien is mostly gone by morning at a 2-3 hour half-life. Lunesta is not. If you take 3mg at 11 PM and your alarm goes off at 6 AM, there’s a real chance you’re going to feel like you’re moving through syrup for the first hour. The FDA actually lowered the recommended starting dose for women a few years back partly because of next-day impairment data, and Lunesta got the same kind of scrutiny Ambien did. You shouldn’t drive at full alertness levels the morning after a 3mg dose. Plan around that, especially the first week.

Second, the taste. This is the most famous Lunesta side effect and almost nobody mentions it on the way out of the pharmacy. It’s a metallic, bitter taste that sits in the back of your mouth and lingers into the next day. About a third of patients get it. Some get it badly enough they quit the medication over it. I had a woman in her late 50s last spring, schoolteacher, came in delighted that Lunesta had finally fixed her 3 AM wake-ups after years of half-sleep. Two months later she was back asking for something else because she said it tasted like she’d been chewing on a battery for sixty-three straight days. We swapped her to low-dose trazodone. The metallic taste is real, it’s annoying, and it’s worth telling people about up front so they’re not blindsided.

The taste thing has a mechanism, by the way. Eszopiclone gets secreted into saliva and that’s what you’re tasting. Brushing your teeth doesn’t fix it. Mints help for about ninety seconds. There’s no good workaround. You either tolerate it or you switch drugs.

Parasomnia, the part nobody likes to talk about

Z-drugs do weird things to a small percentage of the people who take them. Sleep-eating, sleep-driving, sleep-texting, sleep-shopping. Ambien is the famous one, the one that ended up in tabloid headlines and on warning labels with a black box. Lunesta is in the same class and gets the same warning, though the rate appears to be somewhat lower in the clinical data. Somewhat lower is not zero.

If you wake up and the cereal box is on the counter and you don’t remember putting it there, that’s the drug. Stop it that day.

The way I screen for this is I ask at every follow-up. Any mornings where you found evidence of something you don’t remember doing? Half-eaten food, texts you didn’t write, a car parked differently than you left it? It happens more than people report it because they don’t connect it to the medication. The rule I give patients is binary. If it happens once, even once, we’re done with this drug. There’s no dose adjustment that makes complex sleep behaviors safe. The FDA put the boxed warning on this class in 2019 and they didn’t do it for fun.

Other things to know. Don’t combine with alcohol, ever. Don’t take it if you’re not actually going to bed for at least seven full hours. Don’t take it after a heavy meal because absorption gets weird. Don’t double up if it didn’t work in twenty minutes. That last one is how people end up with the parasomnia stuff, by chasing the sleep with a second dose at 1 AM.

The weird FDA quirk about duration

Here’s something interesting and underappreciated. Lunesta is the only hypnotic on the US market approved without a maximum duration of use. Ambien, Sonata, Restoril, all of them have language in the labeling that says short-term use, usually meaning seven to ten days, sometimes up to a month. Lunesta’s label doesn’t have that limit. Sepracor got long-term efficacy data through six months and FDA accepted it.

That doesn’t mean you should take it for six months. It means the regulatory ceiling is missing, not that it’s a good idea to live on it. In actual clinical practice, tolerance still develops, rebound insomnia still happens when you stop, and dependence is a real risk at any duration past a couple of months. I write short courses. Two to four weeks usually, sometimes longer for chronic patterns that haven’t responded to anything else. The label flexibility is useful for the patient who genuinely needs eight weeks instead of two, not as permission for indefinite use.

When to pick Lunesta over Ambien (and when to pick neither)

Quick decision tree. If the problem is falling asleep and you sleep fine once you’re out, Ambien is the simpler choice. Shorter half-life, cleaner morning. If the problem is staying asleep, waking at 2 or 3 AM and lying there until 5, Lunesta makes more sense. The molecule is built for that pattern. If the problem is anxiety-driven insomnia, neither one is what you actually want. You want to treat the anxiety. If the problem is depression-driven insomnia, low-dose trazodone or mirtazapine usually works better than either Z-drug.

And the thing every honest psychiatrist will tell you about chronic insomnia is that the real first-line treatment isn’t a pill at all. It’s CBT-I, the cognitive behavioral therapy specifically built for sleep. Sleep restriction, stimulus control, cognitive work on the catastrophizing about sleep. The data on CBT-I has been steady for thirty years. It works as well as hypnotics in the short term and dramatically better at one year out, because nothing’s wearing off and there’s no tolerance to develop. The trouble is it’s slow, it’s uncomfortable for the first two weeks, and most people would rather take a pill. I get it. I still bring it up at every visit.

Lunesta is a real tool. It’s not a bad drug. It’s a reasonable choice for the right pattern of insomnia in the right patient for the right duration. It is not, despite what the label technically allows, something to settle into for years. The patients who do the best with it are the ones who use it as a bridge, while we work on the sleep hygiene and the CBT-I and whatever else is keeping them up at 3 AM. The patients who do the worst are the ones who decide it’s the answer and stop asking what the question was.